OS Therapies Statistics
NYSE: OSTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.803-0.0174 (-2.12%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
OS Therapies by the numbers
OS Therapies has a market capitalization of $42.0 million based on 52.30M shares outstanding. With trailing EPS of $-1.08, OS Therapies is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 39.6% below its 50-day average and 47.3% below its 200-day average.
Average daily trading volume is 722.66K shares, or about $580,300 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OSTX valuation vs. peer median
| Metric | OSTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $42.00M | $41.89M | +0% |
| Avg. volume | 722.66K | 427.58K | +69% |
Peer median across 8 companies: INCR, BMEA, CRBP, MREO, ELTX, TLPH, SPRO, RLYB.
Valuation
- Market cap
- $42.00M
- Forward P/E
- 2.29
- EPS (TTM)
- $-1.08
- Shares outstanding
- 52.30M
Price and trading
- Previous close
- 0.8204
- Open
- 0.8094
- Day range
- 0.7901 – 0.8625
- 52-week range
- 0.58 – 2.25
- 52-week change
- -53.04%
- Beta
- —
- Volume
- 489.73K
- Average volume
- 722.66K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 17, 2026
Additional statistics
- Market Cap
- 42.00M
- Forward Pe
- 2.29
- Eps
- -1.08
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.25
- Week52 Low
- 0.58
- Avg Volume
- 722.66K
- Shares Outstanding
- 52.30M
- Ma50
- 1.33
- Ma200
- 1.52
- Earnings Date
- Nov 17, 2026
- Pct From52w High
- -64.31%
- Pct From52w Low
- 38.45%